Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Shoptaw

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Hepatology Communications|October 14, 2025
One in 4 transplant hepatologists in the United States screens positive for unhealthy alcohol useChristopher Coe, Nicole Prause, Jihane N Benhammou, et al.
Journal of Addiction Medicine|November 18, 2021
Synergistic Effect of Ketamine and Buprenorphine Observed in the Treatment of Buprenorphine Precipitated Opioid Withdrawal in a Patient With Fentanyl UseChristian Hailozian, Joshua Luftig, Amy Liang, et al.
Plos One|February 3, 2022
Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles CountyOluwadamilola Jolayemi, Laura M Bogart, Erik D Storholm, et al.
Drug and Alcohol Dependence Reports|April 26, 2024
Sociodemographic and patient reported outcomes by racial and ethnicity status among participants in a randomized controlled trial for methamphetamine use disorderChukwuemeka N Okafor, Thomas Carmody, Angela L Stotts, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 1, 2014
Sexual risk trajectories among MSM in the United States: implications for pre-exposure prophylaxis deliveryHeather A Pines, Pamina M Gorbach, Robert E Weiss, et al.
Drug and Alcohol Dependence|June 28, 2025
Mirtazapine reduces hypothetical methamphetamine demand in humansCraig R Rush, Glenn-Milo Santos, Vanessa M McMahan, et al.
Substance Use & Misuse|February 1, 2019
Association of Marijuana Use with Changes in Cognitive Processing Speed and Flexibility for 17 Years in HIV-Seropositive and HIV-Seronegative MenChukwuemeka N Okafor, Michael W Plankey, Michael Li, et al.
Drug and Alcohol Review|December 22, 2019
Contingency management treatment for methamphetamine use disorder in South AfricaChukwuemeka N Okafor, Dan J Stein, Lisa Dannatt, et al.
AIDS and Behavior|July 24, 2024
Disrupting the Path from Depression to Loneliness: Multilevel Resilience among Older Sexual Minority Men with and without HIVMaria De Jesus, Deanna Ware, Steven Meanley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 15, 2013
Not just the needle: the state of HIV-prevention science among substance users and future directionsSteve Shoptaw, Brooke Montgomery, Chyvette T Williams, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Hepatology Communications|October 14, 2025
One in 4 transplant hepatologists in the United States screens positive for unhealthy alcohol useChristopher Coe, Nicole Prause, Jihane N Benhammou, et al.
Journal of Addiction Medicine|November 18, 2021
Synergistic Effect of Ketamine and Buprenorphine Observed in the Treatment of Buprenorphine Precipitated Opioid Withdrawal in a Patient With Fentanyl UseChristian Hailozian, Joshua Luftig, Amy Liang, et al.
Plos One|February 3, 2022
Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles CountyOluwadamilola Jolayemi, Laura M Bogart, Erik D Storholm, et al.
Drug and Alcohol Dependence Reports|April 26, 2024
Sociodemographic and patient reported outcomes by racial and ethnicity status among participants in a randomized controlled trial for methamphetamine use disorderChukwuemeka N Okafor, Thomas Carmody, Angela L Stotts, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 1, 2014
Sexual risk trajectories among MSM in the United States: implications for pre-exposure prophylaxis deliveryHeather A Pines, Pamina M Gorbach, Robert E Weiss, et al.
Drug and Alcohol Dependence|June 28, 2025
Mirtazapine reduces hypothetical methamphetamine demand in humansCraig R Rush, Glenn-Milo Santos, Vanessa M McMahan, et al.
Substance Use & Misuse|February 1, 2019
Association of Marijuana Use with Changes in Cognitive Processing Speed and Flexibility for 17 Years in HIV-Seropositive and HIV-Seronegative MenChukwuemeka N Okafor, Michael W Plankey, Michael Li, et al.
Drug and Alcohol Review|December 22, 2019
Contingency management treatment for methamphetamine use disorder in South AfricaChukwuemeka N Okafor, Dan J Stein, Lisa Dannatt, et al.
AIDS and Behavior|July 24, 2024
Disrupting the Path from Depression to Loneliness: Multilevel Resilience among Older Sexual Minority Men with and without HIVMaria De Jesus, Deanna Ware, Steven Meanley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 15, 2013
Not just the needle: the state of HIV-prevention science among substance users and future directionsSteve Shoptaw, Brooke Montgomery, Chyvette T Williams, et al.
Pageof 14